A relationship between serum concentrations of ionized calcium and parathyroid hormone (PTH) in persons without parathyroid over activity was defined by performing an oral calcium load test. As a result, a serum PTH concentration greater than 2· 6 pmol/L in a hypercalcaemic patient was regarded as suggestive of hyperparathyroidism. Fasting serum PTH concentrations in 58 patients with surgically and histologically proven primary hyperparathyroidism (PHPD were all above 2· 7 pmol/L (range 3' 2-84' 5). Thirteen of 20 patients with familial benign hypercalcaemia (FBH) had fasting serum PTH concentrations greater than 2· 6 pmollL (range 1'6-6'1). There was a significant correlation between serum PTH and age in the FBH patients only. Fasting urine calcium excretion (CaE) ranged from 14 to 222 p.mol/L of glomerular filtrate in PHPT and 3-34 p.mol/L of glomerular filtrate in FBH. The best biochemical discriminant between patients with PHPT and FBH was a plot of fasting serum PTH against CaE' A plot of post-calcium load PTH against post-load CaE showed no further significant advantage in discriminating between the two conditions.
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Most patients with biochemical evidence of primary hyperparathyroidism (PHPT) are referred to a parathyroid surgeon, even if symptoms are mild or absent.t-' The advent of technology enabling measurement of the intact PTH molecule in serum has improved our ability to diagnose PHPT biochemically.v' but the lower limit of serum PTH concentration in patients with proven PHPT has not been established. The inherited condition familial benign hypercalcaemia (FBH) is recognized as one which can be difficult to distinguish from PHPT biochemically. 5 FBH is characterized by asymptomatic hypercalcaemia beginning early in life. It is inherited in an autosomal dominant pattern with high penetrance. Patients with FBH should not be advised to undergo parathyroid surgery. The condition probably accounts for around 10070 of cases of unsuccessful parathyroid explorations. ' We have studied a number of blood and urine measurements to try to achieve Correspondence: Dr Ian R Gunn.
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clear distinction among patients without parathyroid pathology, patients with PHPT and those with FBH.
SUBJECTS AND METHODS
Healthy volunteers comprised 38 laboratory workers (19 women, 19 men, age range 18-60).
Fifty-eight patients (43 females, 15 males, age range 24-90) had histologically proven PH PT. Fifty had a single adenoma, and the remaining eight had two or three enlarged overactive glands. None had diffuse hyperplasia of all four glands. Three of the eight with more than one enlarged gland developed post-operative hypocalcaemia which required treatment with vitamin D. In two cases, the diagnosis of PHPT had been confirmed at post-mortem examination, but in the other 53 cases stable normocalcaemia was achieved postoperatively without calcium or vitamin D therapy.
Twenty patients (12 females, 8 males, age range 9-69) from four different families had FBH. reaction, serum and urine phosphate concentrations by a phosphomolybdate reaction and serum PTH by an intact molecule IRMA (Allegro, Biogenesis, Bournemouth, UK), the values being converted from ng/L to pmoIlL by dividing by 9· 5. The between-batch precision of the PTH assay over the period of the study was 12·2070 CV at 1·7 pmoIlL, 4·4% CV at 5· 4 pmoIlL and 3·6% CV at 24· 8 pmoIlL. Sera for PTH assay were separated from cells within I h of venepuncture and stored at -20°C until analysis.
The number of cases in each family ranged from three to seven. In one family, the index case was diagnosed after referral from elsewhere after unsuccessful neck exploration. The other three index cases were diagnosed locally as part of the investigation of their hypercalcaemia. Family studies were pursued on the basis of relatively low fasting urine calcium excretions (CaE) less than 30ILmoIlL of glomerular filtrate. [CaE =(fasting urine calcium concentration/urine creatinine concentration) X serum creatinine concentration. ] The other 16 cases were diagnosed during followup investigations of the family of each index case.
The criteria for diagnosis of FBH were: a clear ionized hypercalcaemia on at least two occasions; the presence of ionized hypercalcaemia in at least one first-degree relative; a pattern of inheritance consistent with autosomal dominant transmission; and the absence of stigmata of multiple endocrine neoplasia within the family.
Other cases of hypercalcaemia were suspected to have FBH, but the diagnosis could not be confirmed by showing the presence of hypercalcaemia in a first-degree relative. Over the 3-year period that the study took place, only one patient in our hospital had a neck exploration which showed four normal parathyroid glands. The diagnosis in her case remains unclear.
The method of administration of a I g calcium load and blood sampling during the calcium load test has been described previously. 6 Urine samples for calcium analysis were acidified on receipt in the laboratory. Post-load urine samples consisted of a complete collection of all urine passed in the 4 h following the calcium load. Twenty-eight patients with PHPT and 16 patients with FBH had a calcium load test. No patient with a base-line total serum calcium concentration more than 3· 2 mmol/L was offered a calcium load test. There was no other deliberate method of selection of patients for this test. Whether it was performed depended on the patient's availability and consent.
The following analytical methods were employed. Serum ionized calcium was measured with a Radiometer ICA-2 (at in-vivo pH by sampling directly from a Vacutainer). Serum total calcium concentration measured with cresolphthaline complexone was adjusted according to the serum albumin concentration mea- ., Single parathyroid adenoma; .. , at least two overactive parathyroids; 0, familial benign hypercalcaemia. The dotted lines represent: (A) highest concentration in fasting normocalcaemic subjects; (8) highest concentration after calcium load in normal subjects.
Urine calcium, magnesium and phosphate clearances
A number of measures of mineral excretion showed significant differences between the PHPT and the FBH group (Table 1) , but none showed complete separation of results ( Table 2 ). The greatest sensitivity and specificity for the diagnosis of FBH was gained by measurement of CaE' Other measurements had poorer discrimination.
In particular, the ratio of magnesium to creatinine clearance was an unhelpful test. The mean of serum magnesium concentration in the FBH patients was 0·85 mmol/L, which did not differ significantly from the mean in control subjects. Figures 4 and 5 show graphs of serum PTH and CaE in the fasting and post-load state in patients with PHPT and FBH. There is good separation of the two groups in Fig. 4 ; the post-load plot does not seem to have improved significantly the ability to discriminate between them. The FBH was significant overlap with the concentrations seen in PHPT in both the fasting and postcalcium load samples.
Serum PTH concentration and fasting urine calcium excretion (Ca F )
There was a significant positive correlation between fasting serum PTH and the age of the patient in the 20 cases of FBH (Fig. 3) . This relationship did not exist in the healthy control subjects and PHPT patients. There was no significant correlation between age and ionized calcium concentration, nor between serum PTH and creatinine concentrations in the FBH group. in patients with PHPT, and from 2· 58 to 2· 96 mrnol/L in patients with FBH. Five patients with PHPT had serum total calcium concentration within the reference range (less than 2·60 mmol/L), and clearly elevated serum ionized calcium concentration (greater than I· 32 mmol/L). Four of these had presented with renal calculi. Figure 2 shows fasting serum PTH concentrations in all patients, and the post-calcium load concentrations in 28 PHPT and 16 FBH cases. All patients with PHPT had fasting serum PTH concentration greater than 2·6 pmol/L (range 3' 2-84' 5), but 10 had a concentration within the normocalcaemic PTH range. The range of fasting serum PTH in FBH patients was 1· 6-6' 1 pmol/L, similar to that seen in healthy normocalcaemic volunteers, but 13 results were inappropriate for hypercalcaemia, and there 
Diabetic patients
Four of 20 cases of FBH, including three in one family, had diabetes mellitus. One of these patients, a 27-year-old woman with poorly controlled insulin-dependent diabetes, had clearances of calcium, magnesium and phosphate relative to creatinine clearance which were much greater than the other patients with FBH (ratios of 0,012,0'073 and 0'47, respectively).
DISCUSSION
The oral calcium load test in volunteer subjects served as a method for the logical interpretation of serum PTH concentrations as 'inappropriate for a hypercalcaemic patient'. The lowest PTH concentration we observed in a surgically proven parathyroid adenoma was 3·2 pmol/L, but our data suggest that values as low as 2' 7 pmol/L may be regarded as suggestive of parathyroid overactivity.
If we accept that the interpretation of serum PTH concentration depends upon the demonstration of hypercalcaemia, then the definition of the hypercalcaemic state assumes Patients with FBH neither require nor benefit from excision of parathyroid tissue.' The discrimination of cases of PHPT from FBH is not always straightforward. Clearly elevated serum whole molecule PTH concentrations have been reported in some patients with FBH. 7 'Inappropriately' elevated concentrations, between 2·7 and 7· 0 pmol/L were present in the majority of our patients. The range of serum PTH concentration in our patients with FBH was very similar to the range in our normocalcaemic healthy volunteers. This finding is consistent with the view that the parathyroid glands have an altered set point at which they respond to extracellular calcium compared with normal individuals." Our finding of a highly significant correlation between age and serum PTH in patients with FBH has not been described previously. It is an unfortunate association, since it is likely to increase the diagnostic difficulty in the age group in which PHPT is most common.
All patients with FBH except one, a poorly controlled diabetic, had a ratio of calcium to creatinine clearance of less than 0'01, a level previously suggested as one which provided good discrimination between PHPT and FBH.8 However, 10 of our 49 patients with PHPT who had this measurement also had a ratio of less than 0·01.
We found that CaE is the best single parameter of urine calcium excretion to differentiate FBH from PHPT (Table 1) . With the sensitivity set at 95%, a value of 22 JLmol/L glomerular filtrate, the specificity of this measurement for FBH was 92070. With the specificity set at 95%, a value of 17 JLmol/L glomerular filtrate, the sensitivity was 70%. These values would have been improved further if we had excluded from the analysis the 27-year-old woman with poorly controlled diabetes mellitus. Hypercalciuria, hypermagnesuria and hyperphosphaturia have all been noted in insulindependent diabetes.v'" and this should be remembered when hypercalcaemic diabetics with inappropriate concentrations of serum PTH are being evaluated. In non-diabetics, we recommend that hypercalcaemic patients with a CaE of less than 25 JLmol/Lglomerular filtrate be considered possible cases of FBH. It is possible that this suggested 'screening value' for FBH is set too low, since it is close to the value which was used during the course of our study to select patients for family investigations. However, 17of 20 cases were diagnosed as part of a family study, or in one case, following an unsuccessful neck exploration. Fig. 4 for key to symbols.
great importance. In most of our cases of PHPT and FBH, the albumin-adjusted serum total calcium concentration was clearly elevated above the values observed in the healthy volunteers. However, in five cases of PHPT and one case of FBH, the serum total calcium concentration (albumin-adjusted) was within the reference range, and the demonstration of hypercalcaemia depended on measurement of ionized calcium. There were no cases of PHPT in which the serum ionized calcium was within the reference range and total calcium was elevated. The trend towards surgical treatment for asymptomatic PHPT seems well established. Furthermore, of 56 neck explorations performed locallyusing these diagnostic procedures, only one failed to show adenomatous/hyperplastic tissue. That case was a 60-year-old woman with a CaE of 199jLmol/L GF. It is possible that she also had FBH. Cases of hypercalciuria and FBH have been described,'! but we have been unable to complete family studies in her case. Our failed exploration rate of I . 811/0 compares well with the rates of between 3% and 8% seen in other studies. 12 It may be possible to achieve a definitive diagnosis of FBH without resorting to family studies by employing a plot of CaE against fasting serum PTH concentration (Fig. 4 ). This strategy was first described by Stuckey et al. 13 with a PTH radioimmunoassay using an antibody directed against the mid-molecule. Our findings suggest that this is also the best approach when using an intact molecule immunoradiometric assay.
We had hoped that a plot of CaE versus serum PTH concentration after a calcium load might further improve the ability to diagnose FBH. We had already shown that it was possible to suppress serum levels of PTH using a standard oral I g calcium load." We were aware of reports that intestinal absorption of calcium is greater in PHPT than FBH,5 and it seemed reasonable to expect that a much greater amount of calcium given orally would be absorbed from the gut and subsequently excreted into the urine in cases of PHPT compared with FBH. In practice, all 16 FBH patients showed a marked increase in CaE following the oral calcium and the discrimination between cases of PHPT and FBH was not significantly improved.
Parathyroid adenoma used to be considered a rare condition, but its prevalence is now considered to be in the region of three per 1000 population. 14 A few years ago it was estimated that FBH was the diagnosis in only one in 200 cases of hypercalcaernia.! Our findings suggest that around one in 20 hypercalcaemic patients with a serum whole-molecule PTH concentration of more than 2'7 pmol/L will have FBH. For levels between 2· 7 and 7· 0 pmol/L, the figure may be as high as one in four.
A suggestion has been made," based on data showing the circadian rhythm of serum PTH in six healthy controls and six patients with PHPT,16 that 1100 h to 1400 h is the optimum time for blood sampling for PTH measurements. However, when the serum PTH is clearly elevated above 7· 0 pmol/L the timing of the blood sample is unlikely to be important. When the level is 'inappropriately' elevated, that is between 2'7 and 7· 0 pmol/L, we believe it is necessary to collect fasting urine and blood samples to measure CaE in order to screen patients for possible FBH. The definitive diagnosis of FBH probably still requires investigation of the patient's family, but should this not be possible, the best biochemical diagnosis is achieved by the graph of CaE versus serum PTH concentration.
